Pitavastatin Decreases Tau levels Via the Inactivation of Rho/ROCK
スポンサーリンク
概要
- 論文の詳細を見る
Epidemiological studies have shown that long-term treatment with statins decreases the risk of developing Alzheimer's disease. Statins have pleiotropic effects by lowering the concentration of isoprenoid intermediates. Although several studies have shown that statins may reduce amyloid beta protein levels, there have been few reports on the interaction between statins and tau. We report here that pitavastatin reduces total and phosphorylated tau levels in a cellular model of tauopathy, and in primary neuronal cultures. The decrease caused by pitavastatin is reversed by the addition of mevalonate, or geranylgeranyl pyrophosphate. The maturation of small G proteins, including RhoA was disrupted by pitavastatin, as was the activity of glycogen synthase kinase 3β (GSK3β), a major tau kinase. Toxin A, inhibitor of glycosylation of small G proteins, and Rho kinase (ROCK) inhibitor decreased phosphorylated tau levels. Rho kinase inhibitor also inactivated glycogen synthase kinase 3β. Although the mechanisms responsible for the reduction in tau protein by pitavastatin require further examination, this report sheds light on possible therapeutic approaches to tauopathy.
論文 | ランダム
- 荷重分散性能に優れた生体骨構造を模倣した固-気体複合材料の提案 : 気体の体積弾性率および寸法の効果について(複合材料)
- 肝穿孔により腹腔内に生蛔虫の游出を認めた一例
- 講演 長寿と生活の質を高める食と栄養〔含 質疑応答〕 (テーマ 食と健康)
- 制作者インタビュー J-WAVE『JAM THE WORLD』--都市の夜に向けた新しいニュース・ワイド (特集 ラジオがニュースだ!)
- 遠隔投射式測深器の試作(沿岸海洋の調査と研究方法に関するシンポジウム)